TechnologyPatent OppositionCompetitive Analysis

Explore the competitive field of Nervous System Drugs where companies are constantly innovating to stay ahead. Discover the latest patent opposition trends, top companies filing and facing patent oppositions, and the most recent patents under dispute. Stay informed on patent activity in Nervous System Drugs technology and learn how to protect your intellectual property.

Get Patent Opposition Report for Nervous System Drugs

Comprehensive Analysis, Strategic Insights & Expert Evaluation – Stay Ahead in Your Patent Challenge.

Download Report

Explore the top companies that have filed the most patent oppositions in the technology industry.

Explore the top companies that have faced the most patent oppositions in the technology industry.

Explore the top law firms that have filed the most patent oppositions in the technology industry.

Patent challenges are becoming increasingly common in the Nervous System Drugs industry as companies work to protect their innovations in a highly competitive market. These legal battles can significantly impact the development and release of new technologies. Below is a list of the latest patents that have been opposed in the Nervous System Drugs industry, offering a snapshot of the ongoing struggles over intellectual property rights. For anyone involved in this industry, understanding these patent disputes is essential for navigating its future.

Last updated on: Aug 21, 2025
Patent NumberTitleApplicantOpposition DateOpposition Name

Get alerts on new patent oppositions in the Nervous System Drugs industry

Methods For Improving Safety Of Blood-Brain Barrier TransportF HOFFMANN LA ROCHEJul 30, 2025ZWICKER SCHNAPPAUF & PARTNER
Methods For Improving Safety Of Blood-Brain Barrier TransportF HOFFMANN LA ROCHEJul 16, 2025JAMES POOLE
Cladribine Regimen For Treating Multiple SclerosisMERCK SERONOJul 16, 2025GENERICS UK
Compositions Comprising 5-Methoxy-N,N-Dimethyltryptamine (5-Meo-Dmt) For Use In Treating Mental DisordersGH RESEARCH IRELANDJul 9, 2025STRAWMAN
Methods For Dose Initiation Of Aripiprazole TreatmentsOTSUKA PHARMACEUTICALJul 9, 2025ZENTIVA
Use Of Cannabinoids In The Treatment Of Seizures Associated With Lennox-Gastaut SyndromeGW RESEARCHJul 8, 2025KRAUS & LEDERER PARTGMBB
Methods For Dose Initiation Of Aripiprazole TreatmentsOTSUKA PHARMACEUTICALJul 8, 2025RUMI
Methods For Dose Initiation Of Aripiprazole TreatmentsOTSUKA PHARMACEUTICALJul 4, 2025SANDOZ
Use Of Riluzole Prodrugs To Treat AtaxiasBIOHAVEN THERAPEUTICSJul 2, 2025KRAUS & LEDERER PARTGMBB
Methods For Dose Initiation Of Aripiprazole TreatmentsOTSUKA PHARMACEUTICALJul 1, 2025STADA ARZNEIMITTEL

To stay ahead in the competitive Nervous System Drugs industry, companies are constantly innovating. Here are the top patents facing oppositions in the Nervous System Drugs industry. Stay informed on the latest opposition trends and learn how to protect your intellectual property.

Last updated on: Aug 21, 2025
Patent NumberGrant DateTitleApplicantTotal Oppositions
Nov 6, 2024Dosing Regimen Associated With Long Acting Injectable Paliperidone EstersJANSSEN PHARMACEUTICA20
Dec 6, 2023Dosing Regimen For Missed Doses For Long-Acting Injectable Paliperidone EstersJANSSEN PHARMACEUTICALS9
Dec 11, 2019Methods Of Treating Hepatic EncephalopathySALIX PHARMACEUTICALS8
Jul 15, 2020Pharmaceutical Combinations Of An Angiotensin Receptor Antagonist And An Nep InhibitorNOVARTIS8
Apr 22, 2020Dosing Regimen For Missed Doses For Long-Acting Injectable Paliperidone EstersJANSSEN PHARMACEUTICA8
Oct 9, 2024Methods For Dose Initiation Of Aripiprazole TreatmentsOTSUKA PHARMACEUTICAL7
Apr 10, 2019Dosage Form Containing Oxycodone And NaloxoneEURO CELTIQUE7
Jan 4, 2017Low Frequency Glatiramer Acetate TherapyYEDA RESEARCH6
Jun 30, 2021Method For Treating Primary InsomniaNEURIM PHARMACEUTICALS6
Dec 16, 2020Methods Of Administering Tetrahydrobiopterin, Associated Compositions, And Methods Of MeasuringBIOMARIN PHARMACEUTICAL5